Attached files

file filename
EX-99.1 - EX-99.1 - Biodel Incd30026_ex99-1.htm



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

______________


FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



Date of report (Date of earliest event reported):  December 18, 2012


BIODEL INC.
(Exact name of registrant as specified in its charter)



Commission File Number 001-33451


 

 

 

Delaware
(State or other jurisdiction of incorporation or organization)

 

90-0136863
(IRS Employer Identification Number)

 

 

 

100 Saw Mill Road

Danbury, Connecticut

(Address of principal executive offices)

 


06810

(Zip code)



(203) 796-5000
(Registrant's telephone number, including area code)



Not Applicable


(Former Name or Former Address, if Changed Since Last Report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


[  ]

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Item 2.02

Results of Operations and Financial Condition.


On December 18, 2012, Biodel Inc. (the "Company") issued a press release (the “Press Release”) announcing its financial results for its fourth fiscal quarter ended September 30, 2012.  The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.


          

The information contained in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act except as expressly set forth by specific reference in such a filing.


Item 9.01   

Financial Statements and Exhibits.


(d)

Exhibits.


The following exhibit relating to Item 2.02 shall be deemed to be furnished and not filed:


99.1

Press Release issued by the Company on December 18, 2012.






2




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



Date:   December 18, 2012

BIODEL INC.



By:  /s/ Gerard J. Michel                                         

       Gerard J. Michel, Chief Financial Officer







3




EXHIBIT INDEX


Exhibit No.

Description


99.1

Press Release issued by the Company on December 18, 2012.



4